IN2013MU02370A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02370A IN2013MU02370A IN2370MU2013A IN2013MU02370A IN 2013MU02370 A IN2013MU02370 A IN 2013MU02370A IN 2370MU2013 A IN2370MU2013 A IN 2370MU2013A IN 2013MU02370 A IN2013MU02370 A IN 2013MU02370A
- Authority
- IN
- India
- Prior art keywords
- present
- inflammation
- prevention
- formula
- pharmaceutical composition
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- RUMVKBSXRDGBGO-UHFFFAOYSA-N indole-3-carbinol Chemical class C1=CC=C[C]2C(CO)=CN=C21 RUMVKBSXRDGBGO-UHFFFAOYSA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/063031 WO2015008202A1 (en) | 2013-07-16 | 2014-07-11 | Indole-3-carbinol derivatives |
| IN2370MU2013 IN2013MU02370A (enrdf_load_stackoverflow) | 2013-07-16 | 2014-07-11 | |
| EA201690236A EA030692B1 (ru) | 2013-07-16 | 2014-07-11 | Производные индол-3-карбинола |
| CA2918277A CA2918277C (en) | 2013-07-16 | 2014-07-11 | Indole-3-carbinol derivatives |
| AU2014291683A AU2014291683B2 (en) | 2013-07-16 | 2014-07-11 | Indole-3-carbinol derivatives |
| JP2016526736A JP6293271B2 (ja) | 2013-07-16 | 2014-07-11 | インドール−３−カルビノール誘導体 |
| ES14759311.5T ES2671998T3 (es) | 2013-07-16 | 2014-07-11 | Derivados de indol-3-carbinol |
| US14/904,734 US9708258B2 (en) | 2013-07-16 | 2014-07-11 | Indole 3-carbinol derivatives |
| EP14759311.5A EP3022177B1 (en) | 2013-07-16 | 2014-07-11 | Indole-3-carbinol derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2370MU2013 IN2013MU02370A (enrdf_load_stackoverflow) | 2013-07-16 | 2014-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02370A true IN2013MU02370A (enrdf_load_stackoverflow) | 2015-06-19 |
Family
ID=52345790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2370MU2013 IN2013MU02370A (enrdf_load_stackoverflow) | 2013-07-16 | 2014-07-11 |
Country Status (9)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906086A (zh) * | 2015-06-24 | 2015-09-16 | 安徽四正医药科技有限公司 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物用于治疗肾小球肾炎药物的应用 |
| EP3820480A4 (en) | 2018-07-11 | 2022-03-09 | Arrys Therapeutics, Inc. | POLYMORPHIC COMPOUNDS AND USES THEREOF |
| CN113260363A (zh) * | 2018-09-27 | 2021-08-13 | 阿瑞斯医疗有限公司 | 格拉普兰特(grapiprant)单位剂型 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002060382A (ja) * | 2000-08-22 | 2002-02-26 | Ajinomoto Co Inc | モナティンの立体異性体及びその使用、並びにモナティン類の製造方法及びそのための中間体 |
| GB0614068D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| US7807705B2 (en) | 2007-05-18 | 2010-10-05 | The Ohio State University Research Foundation | Potent indole-3-carbinol-derived antitumor agents |
| US8153680B2 (en) | 2009-08-25 | 2012-04-10 | The Ohio State University Research Foundation | Alkyl indole-3-carbinol-derived antitumor agents |
-
2014
- 2014-07-11 EP EP14759311.5A patent/EP3022177B1/en not_active Not-in-force
- 2014-07-11 IN IN2370MU2013 patent/IN2013MU02370A/en unknown
- 2014-07-11 CA CA2918277A patent/CA2918277C/en active Active
- 2014-07-11 ES ES14759311.5T patent/ES2671998T3/es active Active
- 2014-07-11 WO PCT/IB2014/063031 patent/WO2015008202A1/en not_active Ceased
- 2014-07-11 JP JP2016526736A patent/JP6293271B2/ja not_active Expired - Fee Related
- 2014-07-11 AU AU2014291683A patent/AU2014291683B2/en not_active Ceased
- 2014-07-11 EA EA201690236A patent/EA030692B1/ru not_active IP Right Cessation
- 2014-07-11 US US14/904,734 patent/US9708258B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2918277A1 (en) | 2015-01-22 |
| EP3022177A1 (en) | 2016-05-25 |
| AU2014291683A1 (en) | 2016-02-18 |
| JP2016527226A (ja) | 2016-09-08 |
| EA201690236A1 (ru) | 2016-07-29 |
| JP6293271B2 (ja) | 2018-03-14 |
| EA030692B1 (ru) | 2018-09-28 |
| EP3022177B1 (en) | 2018-03-28 |
| AU2014291683B2 (en) | 2017-11-02 |
| US9708258B2 (en) | 2017-07-18 |
| US20160159740A1 (en) | 2016-06-09 |
| CA2918277C (en) | 2021-02-16 |
| ES2671998T3 (es) | 2018-06-12 |
| WO2015008202A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
| PH12016500582B1 (en) | Heterocyclic compounds and uses thereof | |
| PH12017500941A1 (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX365939B (es) | Moduladores del transporte nuclear y usos de los mismos. | |
| CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| MY192717A (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| PH12014500468A1 (en) | Heterocyclic compounds and uses thereof | |
| EA201691032A1 (ru) | Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ | |
| BR112016012146A2 (pt) | Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos | |
| MA39726A (fr) | Compositions pharmaceutiques de composés thérapeutiquement actifs | |
| EA201692313A1 (ru) | Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ | |
| MX2016011865A (es) | Composiciones farmaceuticas de compuestos terapeuticamente activos. | |
| PH12014501078A1 (en) | Pharmaceutical compositions and methods of use of 4-pregenen-11�-17-21-triol-3,20-dione derivatives | |
| CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
| PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
| IN2013MU03641A (enrdf_load_stackoverflow) | ||
| EA201400444A1 (ru) | Производные 2-оксопиперидинила | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| IN2013MU02370A (enrdf_load_stackoverflow) | ||
| MX2016002930A (es) | Moduladores del receptor x hepatico (lxr). | |
| MX371343B (es) | Moduladores del receptor x hepatico (lxr). | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| MX2015012393A (es) | Derivados oxindol con un sustituyente oxetano y uso de los mismos para tratar enfermedades relacionadas con la vasopresina. |